Global CAR T-cell Therapy Drug Market Growth (Status and Outlook) 2022-2028
- LP 4977931
- 88 Pages
- July 2022
- Pharmaceuticals
The United States CAR T-cell Therapy Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global CAR T-cell Therapy Drug market, reaching US$ million by the year 2028. As for the Europe CAR T-cell Therapy Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main CAR T-cell Therapy Drug players cover Novartis, Gilead Sciences, Bristol-Myers Squibb, and J & J, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CAR T-cell Therapy Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CD19-targeted
BCMA-targeted
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Lymphoma
Multiple Myeloma
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Novartis
Gilead Sciences
Bristol-Myers Squibb
J & J
JW Therapeutics
FOSUNKite
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CAR T-cell Therapy Drug Market Size 2017-2028
2.1.2 CAR T-cell Therapy Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CAR T-cell Therapy Drug Segment by Type
2.2.1 CD19-targeted
2.2.2 BCMA-targeted
2.3 CAR T-cell Therapy Drug Market Size by Type
2.3.1 CAR T-cell Therapy Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
2.4 CAR T-cell Therapy Drug Segment by Application
2.4.1 Lymphoma
2.4.2 Multiple Myeloma
2.5 CAR T-cell Therapy Drug Market Size by Application
2.5.1 CAR T-cell Therapy Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
3 CAR T-cell Therapy Drug Market Size by Player
3.1 CAR T-cell Therapy Drug Market Size Market Share by Players
3.1.1 Global CAR T-cell Therapy Drug Revenue by Players (2020-2022)
3.1.2 Global CAR T-cell Therapy Drug Revenue Market Share by Players (2020-2022)
3.2 Global CAR T-cell Therapy Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CAR T-cell Therapy Drug by Regions
4.1 CAR T-cell Therapy Drug Market Size by Regions (2017-2022)
4.2 Americas CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.3 APAC CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.4 Europe CAR T-cell Therapy Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa CAR T-cell Therapy Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas CAR T-cell Therapy Drug Market Size by Country (2017-2022)
5.2 Americas CAR T-cell Therapy Drug Market Size by Type (2017-2022)
5.3 Americas CAR T-cell Therapy Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CAR T-cell Therapy Drug Market Size by Region (2017-2022)
6.2 APAC CAR T-cell Therapy Drug Market Size by Type (2017-2022)
6.3 APAC CAR T-cell Therapy Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CAR T-cell Therapy Drug by Country (2017-2022)
7.2 Europe CAR T-cell Therapy Drug Market Size by Type (2017-2022)
7.3 Europe CAR T-cell Therapy Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CAR T-cell Therapy Drug by Region (2017-2022)
8.2 Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CAR T-cell Therapy Drug Market Forecast
10.1 Global CAR T-cell Therapy Drug Forecast by Regions (2023-2028)
10.1.1 Global CAR T-cell Therapy Drug Forecast by Regions (2023-2028)
10.1.2 Americas CAR T-cell Therapy Drug Forecast
10.1.3 APAC CAR T-cell Therapy Drug Forecast
10.1.4 Europe CAR T-cell Therapy Drug Forecast
10.1.5 Middle East & Africa CAR T-cell Therapy Drug Forecast
10.2 Americas CAR T-cell Therapy Drug Forecast by Country (2023-2028)
10.2.1 United States CAR T-cell Therapy Drug Market Forecast
10.2.2 Canada CAR T-cell Therapy Drug Market Forecast
10.2.3 Mexico CAR T-cell Therapy Drug Market Forecast
10.2.4 Brazil CAR T-cell Therapy Drug Market Forecast
10.3 APAC CAR T-cell Therapy Drug Forecast by Region (2023-2028)
10.3.1 China CAR T-cell Therapy Drug Market Forecast
10.3.2 Japan CAR T-cell Therapy Drug Market Forecast
10.3.3 Korea CAR T-cell Therapy Drug Market Forecast
10.3.4 Southeast Asia CAR T-cell Therapy Drug Market Forecast
10.3.5 India CAR T-cell Therapy Drug Market Forecast
10.3.6 Australia CAR T-cell Therapy Drug Market Forecast
10.4 Europe CAR T-cell Therapy Drug Forecast by Country (2023-2028)
10.4.1 Germany CAR T-cell Therapy Drug Market Forecast
10.4.2 France CAR T-cell Therapy Drug Market Forecast
10.4.3 UK CAR T-cell Therapy Drug Market Forecast
10.4.4 Italy CAR T-cell Therapy Drug Market Forecast
10.4.5 Russia CAR T-cell Therapy Drug Market Forecast
10.5 Middle East & Africa CAR T-cell Therapy Drug Forecast by Region (2023-2028)
10.5.1 Egypt CAR T-cell Therapy Drug Market Forecast
10.5.2 South Africa CAR T-cell Therapy Drug Market Forecast
10.5.3 Israel CAR T-cell Therapy Drug Market Forecast
10.5.4 Turkey CAR T-cell Therapy Drug Market Forecast
10.5.5 GCC Countries CAR T-cell Therapy Drug Market Forecast
10.6 Global CAR T-cell Therapy Drug Forecast by Type (2023-2028)
10.7 Global CAR T-cell Therapy Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis CAR T-cell Therapy Drug Product Offered
11.1.3 Novartis CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Information
11.2.2 Gilead Sciences CAR T-cell Therapy Drug Product Offered
11.2.3 Gilead Sciences CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Gilead Sciences Main Business Overview
11.2.5 Gilead Sciences Latest Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Information
11.3.2 Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
11.3.3 Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Bristol-Myers Squibb Main Business Overview
11.3.5 Bristol-Myers Squibb Latest Developments
11.4 J & J
11.4.1 J & J Company Information
11.4.2 J & J CAR T-cell Therapy Drug Product Offered
11.4.3 J & J CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 J & J Main Business Overview
11.4.5 J & J Latest Developments
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Information
11.5.2 JW Therapeutics CAR T-cell Therapy Drug Product Offered
11.5.3 JW Therapeutics CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 JW Therapeutics Main Business Overview
11.5.5 JW Therapeutics Latest Developments
11.6 FOSUNKite
11.6.1 FOSUNKite Company Information
11.6.2 FOSUNKite CAR T-cell Therapy Drug Product Offered
11.6.3 FOSUNKite CAR T-cell Therapy Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 FOSUNKite Main Business Overview
11.6.5 FOSUNKite Latest Developments
12 Research Findings and Conclusion
Table 1. CAR T-cell Therapy Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CD19-targeted
Table 3. Major Players of BCMA-targeted
Table 4. CAR T-cell Therapy Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 7. CAR T-cell Therapy Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 10. Global CAR T-cell Therapy Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global CAR T-cell Therapy Drug Revenue Market Share by Player (2020-2022)
Table 12. CAR T-cell Therapy Drug Key Players Head office and Products Offered
Table 13. CAR T-cell Therapy Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global CAR T-cell Therapy Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas CAR T-cell Therapy Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas CAR T-cell Therapy Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC CAR T-cell Therapy Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC CAR T-cell Therapy Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe CAR T-cell Therapy Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe CAR T-cell Therapy Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa CAR T-cell Therapy Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa CAR T-cell Therapy Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa CAR T-cell Therapy Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of CAR T-cell Therapy Drug
Table 43. Key Market Challenges & Risks of CAR T-cell Therapy Drug
Table 44. Key Industry Trends of CAR T-cell Therapy Drug
Table 45. Global CAR T-cell Therapy Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global CAR T-cell Therapy Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global CAR T-cell Therapy Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global CAR T-cell Therapy Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Novartis Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 52. Novartis CAR T-cell Therapy Drug Product Offered
Table 53. Novartis CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Novartis Main Business
Table 55. Novartis Latest Developments
Table 56. Gilead Sciences Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 57. Gilead Sciences CAR T-cell Therapy Drug Product Offered
Table 58. Gilead Sciences Main Business
Table 59. Gilead Sciences CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Gilead Sciences Latest Developments
Table 61. Bristol-Myers Squibb Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 62. Bristol-Myers Squibb CAR T-cell Therapy Drug Product Offered
Table 63. Bristol-Myers Squibb Main Business
Table 64. Bristol-Myers Squibb CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Bristol-Myers Squibb Latest Developments
Table 66. J & J Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 67. J & J CAR T-cell Therapy Drug Product Offered
Table 68. J & J Main Business
Table 69. J & J CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. J & J Latest Developments
Table 71. JW Therapeutics Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 72. JW Therapeutics CAR T-cell Therapy Drug Product Offered
Table 73. JW Therapeutics Main Business
Table 74. JW Therapeutics CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. JW Therapeutics Latest Developments
Table 76. FOSUNKite Details, Company Type, CAR T-cell Therapy Drug Area Served and Its Competitors
Table 77. FOSUNKite CAR T-cell Therapy Drug Product Offered
Table 78. FOSUNKite Main Business
Table 79. FOSUNKite CAR T-cell Therapy Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. FOSUNKite Latest Developments
List of Figures
Figure 1. CAR T-cell Therapy Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CAR T-cell Therapy Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 7. CAR T-cell Therapy Drug in Lymphoma
Figure 8. Global CAR T-cell Therapy Drug Market: Lymphoma (2017-2022) & ($ Millions)
Figure 9. CAR T-cell Therapy Drug in Multiple Myeloma
Figure 10. Global CAR T-cell Therapy Drug Market: Multiple Myeloma (2017-2022) & ($ Millions)
Figure 11. Global CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 12. Global CAR T-cell Therapy Drug Revenue Market Share by Player in 2021
Figure 13. Global CAR T-cell Therapy Drug Market Size Market Share by Regions (2017-2022)
Figure 14. Americas CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 15. APAC CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 16. Europe CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa CAR T-cell Therapy Drug Market Size 2017-2022 ($ Millions)
Figure 18. Americas CAR T-cell Therapy Drug Value Market Share by Country in 2021
Figure 19. Americas CAR T-cell Therapy Drug Consumption Market Share by Type in 2021
Figure 20. Americas CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 21. United States CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC CAR T-cell Therapy Drug Market Size Market Share by Region in 2021
Figure 26. APAC CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 27. China CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. India CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe CAR T-cell Therapy Drug Market Size Market Share by Country in 2021
Figure 34. Europe CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 35. Europe CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 36. Germany CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. France CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa CAR T-cell Therapy Drug Market Size Market Share by Application in 2021
Figure 44. Egypt CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country CAR T-cell Therapy Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 50. APAC CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 51. Europe CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 53. United States CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 54. Canada CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 55. Mexico CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 56. Brazil CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 57. China CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 58. Japan CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 59. Korea CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 61. India CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 62. Australia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 63. Germany CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 64. France CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 65. UK CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 66. Italy CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 67. Russia CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 68. Spain CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 69. Egypt CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 70. South Africa CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 71. Israel CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 72. Turkey CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries CAR T-cell Therapy Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
